Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease (2021)
- Authors:
- USP affiliated authors: GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM ; PASSARELLI, MARISA - FM
- Unidade: FM
- DOI: 10.1016/j.jdiacomp.2021.107969
- Subjects: NEFROPATIAS; COLESTEROL; DIABETES MELLITUS; ALBUMINAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of diabetes and its complications
- ISSN: 1056-8727
- Volume/Número/Paginação/Ano: v. 35, n. 9, article ID 107969, 8p, 2021
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LIRA, Aecio Lopes de Araujo et al. Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease. Journal of diabetes and its complications, v. 35, n. 9, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jdiacomp.2021.107969. Acesso em: 04 jun. 2024. -
APA
Lira, A. L. de A., Santana, M. de F. M., Pinto, R. de S., Minanni, C. A., Iborra, R. T., Lima, A. M. S. de, et al. (2021). Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease. Journal of diabetes and its complications, 35( 9). doi:10.1016/j.jdiacomp.2021.107969 -
NLM
Lira AL de A, Santana M de FM, Pinto R de S, Minanni CA, Iborra RT, Lima AMS de, Giannella MLCC, Passarelli M, Queiroz MS. Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease [Internet]. Journal of diabetes and its complications. 2021 ; 35( 9):[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.jdiacomp.2021.107969 -
Vancouver
Lira AL de A, Santana M de FM, Pinto R de S, Minanni CA, Iborra RT, Lima AMS de, Giannella MLCC, Passarelli M, Queiroz MS. Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease [Internet]. Journal of diabetes and its complications. 2021 ; 35( 9):[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.jdiacomp.2021.107969 - Dual effect of advanced glycation end products (AGES) in pancreatic isler apoptosis and the protective role of benfotiamine and mitoq
- Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors
- Micro-RNAs 518d-3p and 618 Are Upregulated in Individuals With Type 1 Diabetes With Multiple Microvascular Complications
- Dual effect of advanced glycation end products in pancreatic islet apoptosis
- The reverse cholesterol transport is impaired by serum albumin isolated from uncontrolled diabetes mellitus patientes
- Oleic and linoleic fatty acids downregulate Slc2a4/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells
- Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport
- Selective inhibition of proteasomal and lysosomal degradation pathways partially prevent abca-1 reduction in macrophages induced by advanced glycated albumin
- In Type 2 Diabetes Mellitus Glycated Albumin Alters Macrophage Gene Expression Impairing ABCA1-Mediated Cholesterol Efflux
- Aminoguanidina e metformina previnem reduções no efluxo de colesterol celular, induzidas por produtos avançados de glicação
Informações sobre o DOI: 10.1016/j.jdiacomp.2021.107969 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
